A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease

计划入组 31 人 · 首次发布于 2025 年 6 月 10 日

Dyskinesia in Parkinson's Disease (Study P04501)

计划入组 253 人 · 首次发布于 2006 年 12 月 4 日

PechaKucha Versus PowerPoint for Parkinson's Disease Education in Nurses

计划入组 72 人 · 首次发布于 2026 年 9 月 2 日

Antisense oligonucleotides

Parkinson's disease therapeutics

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

Rare Disease Research, LLC

The Michael J. Fox Foundation For Parkinson's Research

United States

Congruence Therapeutics and Ono Pharmaceutical Expand Partnership to Target Neurology and Immunology Programs

Bial's Phase 2b ACTIVATE Study Reaches 75% Completion Milestone for GBA1-Associated Parkinson's Disease Treatment

Bial Completes Phase 2b ACTIVATE Study of Potential First-in-Class GBA1 Parkinson's Treatment